Cargando…

Preoperative treatment with metyrapone in patients with Cushing’s syndrome due to adrenal adenoma: a pilot prospective study

OBJECTIVE: Metyrapone has been approved for the treatment of patients with Cushing’s syndrome (CS), but only few retrospective clinical studies are available. The aim of our study was the prospective assessment of metyrapone as pre-operative treatment. DESIGN AND METHODS: Before adrenalectomy, seven...

Descripción completa

Detalles Bibliográficos
Autores principales:	Puglisi, Soraya, Perotti, Paola, Barbot, Mattia, Cosio, Paolo, Scaroni, Carla, Stigliano, Antonio, Lardo, Pina, Morelli, Valentina, Polledri, Elisa, Chiodini, Iacopo, Reimondo, Giuseppe, Pia, Anna, Terzolo, Massimo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Bioscientifica Ltd 2018
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6215797/ https://www.ncbi.nlm.nih.gov/pubmed/30352400 http://dx.doi.org/10.1530/EC-18-0400

Ejemplares similares

Analysis of BCLI, N363S and ER22/23EK Polymorphisms of the Glucocorticoid Receptor Gene in Adrenal Incidentalomas
por: Reimondo, Giuseppe, et al.
Publicado: (2016)

Adrenal Cushing’s in Pregnancy, Managed with Metyrapone to Optimize for Adrenalectomy at 27 Weeks Gestation
por: Shah, Leena, et al.
Publicado: (2021)

Adrenal Cushing Syndrome Diagnosed During Pregnancy: Successful Medical Management With Metyrapone
por: Azzola, Alescia, et al.
Publicado: (2020)

Is Follow-up of Adrenal Incidentalomas Always Mandatory?
por: Reimondo, Giuseppe, et al.
Publicado: (2020)

SAT-365 Prevalence and Clinical Features of Adrenal Incidentalomas: A Prospective Study in an Unselected Population
por: Castellano, Elena, et al.
Publicado: (2019)

Metyrapone for Long-Term Medical Management of Cushing's Syndrome
por: Traina, Andrea N., et al.
Publicado: (2013)

Cushing Disease Treated Successfully With Metyrapone During Pregnancy
por: Bass, Ilana Ramer, et al.
Publicado: (2021)

Diabetes Mellitus Secondary to Cushing’s Disease
por: Barbot, Mattia, et al.
Publicado: (2018)

The Pathophysiology and Treatment of Hypertension in Patients With Cushing's Syndrome
por: Barbot, Mattia, et al.
Publicado: (2019)

Unwanted Hormonal and Metabolic Effects of Postoperative Adjuvant Mitotane Treatment for Adrenocortical Cancer
por: Basile, Vittoria, et al.
Publicado: (2020)

Limited Role of Hair Cortisol and Cortisone Measurement for Detecting Cortisol Autonomy in Patients With Adrenal Incidentalomas
por: Puglisi, Soraya, et al.
Publicado: (2022)

Consideration on TMPRSS2 and the risk of COVID-19 infection in Cushing’s syndrome
por: Barbot, Mattia, et al.
Publicado: (2020)

Long-term Treatment With Metyrapone in a Man With Ectopic Cushing Syndrome
por: Wong, Tin Wai
Publicado: (2022)

Adrenal Hyperplasia as Possible Predictor of Mortality in Patients Admitted for Suspected SARS-Cov-2 Infection: A Prospective Study
por: Reimondo, Giuseppe, et al.
Publicado: (2021)

Tumor Shrinkage by Metyrapone in Cushing Disease Exhibiting Glucocorticoid-Induced Positive Feedback
por: Tsujimoto, Yasutaka, et al.
Publicado: (2021)

Molecular Mechanisms of Mitotane Action in Adrenocortical Cancer Based on In Vitro Studies
por: Lo Iacono, Marco, et al.
Publicado: (2021)

Metyrapone Treatment in Endogenous Cushing’s Syndrome: Results at Week 12 From PROMPT, a Prospective International Multicenter, Open-Label, Phase III/IV Study
por: Nieman, Lynnette K, et al.
Publicado: (2021)

Evaluation of Midnight Salivary Cortisol as a Predictor Factor for Common Carotid Arteries Intima Media Thickness in Patients with Clinically Inapparent Adrenal Adenomas
por: Reimondo, Giuseppe, et al.
Publicado: (2015)

Cushing syndrome in pregnancy secondary to adrenal adenoma
por: Chang, Ikjin, et al.
Publicado: (2013)

Effects of SGLT2 Inhibitors and GLP-1 Receptor Agonists on Renin-Angiotensin-Aldosterone System
por: Puglisi, Soraya, et al.
Publicado: (2021)

RF21 | PSAT99 Urinary adrenal steroidome modifications by Ketoconazole and Metyrapone alter the urinary free cortisol immunoassay reliability in Cushing Syndrome
por: Vega-Beyhart, Arturo, et al.
Publicado: (2022)

The Role of Glucocorticoid Receptor in the Pathophysiology of Pituitary Corticotroph Adenomas
por: Regazzo, Daniela, et al.
Publicado: (2022)

Female Sexual Dysfunction in Primary Adrenal Insufficiency
por: Zamponi, Virginia, et al.
Publicado: (2021)

Evaluation of plasma ACTH in the metyrapone test is insufficient for the diagnosis of secondary adrenal insufficiency
por: Papierska, Lucyna, et al.
Publicado: (2022)

Metabolic syndrome and cardiovascular morbidity in patients with congenital adrenal hyperplasia
por: Barbot, Mattia, et al.
Publicado: (2022)

SUN-LB068 Ectopic Cushing Syndrome Due to a Metastatic Neuroendocrine Tumor Treated with Metyrapone
por: Tsomos, Effie, et al.
Publicado: (2019)

OR12-1 Activity of Abiraterone Acetate in the management of Cushing syndrome associated to advanced adrenocortical carcinoma: results of the ABACUS trial.
por: Abate, Andrea, et al.
Publicado: (2022)

Mitotane Concentrations Influence the Risk of Recurrence in Adrenocortical Carcinoma Patients on Adjuvant Treatment
por: Puglisi, Soraya, et al.
Publicado: (2019)

Acute Primary Adrenal Insufficiency after Hip Replacement in a Patient with Acute Intermittent Porphyria
por: Latina, Adele, et al.
Publicado: (2018)

Defining Nonfunctioning Adrenal Adenomas on the Basis of the Occurrence of Hypocortisolism after Adrenalectomy
por: Eller-Vainicher, Cristina, et al.
Publicado: (2020)

Incretin Response to Mixed Meal Challenge in Active Cushing’s Disease and after Pasireotide Therapy
por: Barbot, Mattia, et al.
Publicado: (2022)

Anastrozole as add-on therapy for cabergoline-resistant prolactin-secreting pituitary adenomas: real-life experience in male patients
por: Ceccato, Filippo, et al.
Publicado: (2021)

What factors have impact on glucocorticoid replacement in adrenal insufficiency: a real-life study
por: Puglisi, S., et al.
Publicado: (2020)

A case of Cushing s syndrome in pregnancy secondary to an adrenal cortical adenoma.
por: Kim, Hwi Gon, et al.
Publicado: (2003)

Black adrenal adenoma causing subclinical Cushing’s syndrome complicated with pheochromocytoma
por: Uketa, Shoko, et al.
Publicado: (2020)

FRI214 Adrenal Adenoma With Biochemical Findings Suggestive Of Cushing's Disease
por: Calimag, Angela Pauline, et al.
Publicado: (2023)

Ketoconazole- and Metyrapone-Induced Reductions on Urinary Steroid Metabolites Alter the Urinary Free Cortisol Immunoassay Reliability in Cushing Syndrome
por: Vega-Beyhart, Arturo, et al.
Publicado: (2022)

Allelic Variants of ARMC5 in Patients With Adrenal Incidentalomas and in Patients With Cushing's Syndrome Associated With Bilateral Adrenal Nodules
por: Mariani, Beatriz Marinho de Paula, et al.
Publicado: (2020)

Metyrapone: Various toxicities: case report
Publicado: (2021)

Approach to patients with pseudo-Cushing’s states
por: Scaroni, Carla, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_50ilo0e71bi5q030hb4stfkhkr